<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is a highly aggressive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> that frequently develops from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, a premalignant pathologic change occurring in the lower end of the esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>Identifying <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> patients at high risk of <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> is essential to the prevention of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Although microRNA (miRNA) expression signatures have been associated with the etiology and prognosis of several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, their roles in the development of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> have not been extensively evaluated </plain></SENT>
<SENT sid="3" pm="."><plain>EXPERIMENTAL DESIGN: In this study, we analyzed the expression patterns of 470 human miRNAs using Agilent miRNA microarray in 32 disease/<z:mpath ids='MPATH_458'>normal</z:mpath>-paired tissues from 16 patients diagnosed with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> of either low- or high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, or esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Using unsupervised hierarchical clustering and class comparison analyses, we found that miRNA expression profiles in tissues of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> were significantly different from their corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="5" pm="."><plain>Similar findings were observed for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, but not for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>The expression patterns of selected miRNAs were further validated using quantitative reverse transcription real-time PCR in an independent set of 75 pairs of disease/<z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, we identified several miRNAs that were involved in the progressions from low grade-<z:mpath ids='MPATH_589'>dysplasia</z:mpath> <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: We showed that miRNAs were involved in the development and progression of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>The identified significant miRNAs that may become potential targets for early detection, chemoprevention, and treatment of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
</text></document>